Search Results - "Schellenberg, Devin"

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial by Palma, David A, Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B, Yaremko, Brian P, Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S, Laba, Joanna, Qu, X Melody, Warner, Andrew, Senan, Suresh

“…The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites…”
Get full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial by Palma, David A, Olson, Robert, Harrow, Stephen, Correa, Rohann J M, Schneiders, Famke, Haasbeek, Cornelis J A, Rodrigues, George B, Lock, Michael, Yaremko, Brian P, Bauman, Glenn S, Ahmad, Belal, Schellenberg, Devin, Liu, Mitchell, Gaede, Stewart, Laba, Joanna, Mulroy, Liam, Senthi, Sashendra, Louie, Alexander V, Swaminath, Anand, Chalmers, Anthony, Warner, Andrew, Slotman, Ben J, de Gruijl, Tanja D, Allan, Alison, Senan, Suresh

“…Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose,…”
Get full text

Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer by Melosky, Barbara, Cheema, Parneet K., Brade, Anthony, McLeod, Deanna, Liu, Geoffrey, Price, Paul Wheatley, Jao, Kevin, Schellenberg, Devin D., Juergens, Rosalyn, Leighl, Natasha, Chu, Quincy

“…Background Small cell lung cancer (SCLC) represents approximately 15% of lung cancers, and approximately 70% are diagnosed as extensive‐stage SCLC (ES‐SCLC)…”
Get full text

Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer by Schellenberg, Devin, M.D, Kim, Jeff, B.S, Christman-Skieller, Claudia, B.A, Chun, Carlene L., B.S., Ph.D, Columbo, Laurie Ann, R.N, Ford, James M., M.D, Fisher, George A., M.D., Ph.D, Kunz, Pamela L., M.D, Van Dam, Jacques, M.D., Ph.D, Quon, Andrew, M.D, Desser, Terry S., M.D, Norton, Jeffrey, M.D, Hsu, Annie, Ph.D, Maxim, Peter G., Ph.D, Xing, Lei, Ph.D, Goodman, Karyn A., M.D, Chang, Daniel T., M.D, Koong, Albert C., M.D., Ph.D

“…Purpose This Phase II trial evaluated the toxicity, local control, and overall survival in patients treated with sequential gemcitabine and linear…”
Get full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial by Olson, Robert, Mathews, Lindsay, Liu, Mitchell, Schellenberg, Devin, Mou, Benjamin, Berrang, Tanya, Harrow, Stephen, Correa, Rohann J M, Bhat, Vasudeva, Pai, Howard, Mohamed, Islam, Miller, Stacy, Schneiders, Famke, Laba, Joanna, Wilke, Derek, Senthi, Sashendra, Louie, Alexander V, Swaminath, Anand, Chalmers, Anthony, Gaede, Stewart, Warner, Andrew, de Gruijl, Tanja D, Allan, Alison, Palma, David A

“…A recent randomized phase II trial evaluated stereotactic ablative radiotherapy (SABR) in a group of patients with a small burden of oligometastatic disease…”
Get full text

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases by Yeung, Rosanna, Hamm, Jeremy, Liu, Mitchell, Schellenberg, Devin

“…In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized…”
Get full text

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial by Olson, Robert, Senan, Suresh, Harrow, Stephen, Gaede, Stewart, Louie, Alexander, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George, Yaremko, Brian, Schellenberg, Devin, Ahmad, Belal, Griffioen, Gwendolyn, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Bauman, Glenn, Warner, Andrew, Palma, David

“…Randomized data assessing the longitudinal quality of life (QoL) impact of stereotactic ablative radiation therapy (SABR) in the oligometastatic setting are…”
Get full text

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer by Schellenberg, Devin, M.D, Goodman, Karyn A., M.D, Lee, Florence, B.S, Chang, Stephanie, B.A, Kuo, Timothy, M.D, Ford, James M., M.D., Ph.D, Fisher, George A., M.D., Ph.D, Quon, Andrew, M.D, Desser, Terry S., M.D, Norton, Jeffrey, M.D, Greco, Ralph, M.D, Yang, George P., M.D., Ph.D, Koong, Albert C., M.D., Ph.D

“…Purpose Fractionated radiotherapy and chemotherapy for locally advanced pancreatic cancer achieves only modest local control. This prospective trial evaluated…”
Get full text

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas by Chang, Daniel T., Schellenberg, Devin, Shen, John, Kim, Jeff, Goodman, Karyn A., Fisher, George A., Ford, James M., Desser, Terry, Quon, Andrew, Koong, Albert C.

“…BACKGROUND: The authors report on the local control and toxicity of stereotactic body radiotherapy (SBRT) for patients with unresectable pancreatic…”
Get full text

Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study by Nichol, Alan, MD, Ma, Roy, MD, Hsu, Fred, MD, Gondara, Lovedeep, PDC, Carolan, Hannah, MD, Olson, Robert, MD, MSc, Schellenberg, Devin, MD, Germain, François, MD, Cheung, Arthur, MD, Peacock, Michael, MD, Bergman, Alanah, PhD, Vollans, Emily, MSc, Vellani, Rosemin, RTT, McKenzie, Michael, MD

“…Purpose Interest is growing in treating multiple brain metastases with radiosurgery. We report on the effectiveness and tolerability of volumetric radiosurgery…”
Get full text

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors by Zhao, Yizhou, Khawandanh, Eman, Thomas, Steven, Zhang, Susan, Dunne, Emma M, Liu, Mitchell, Schellenberg, Devin

“…For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC) lung tumors, our provincial practice has been to prioritize organs at risk…”
Get full text

Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment by Kellock, Trenton, Liang, Teresa, Harris, Alison, Schellenberg, Devin, Ma, Roy, Ho, Stephen, Yap, Wan Wan

“…Surgical resection, when feasible, is the standard of care for hepatocellular carcinoma. However, many tumours are not resectable at the time of diagnosis…”
Get full text

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET by Olson, Robert, Abraham, Hadassah, Leclerc, Curtis, Benny, Alexander, Baker, Sarah, Matthews, Quinn, Chng, Nick, Bergman, Alanah, Mou, Benjamin, Dunne, Emma M, Schellenberg, Devin, Jiang, Will, Chan, Elisa, Atrchian, Siavash, Lefresne, Shilo, Carolan, Hannah, Valev, Boris, Tyldesley, Scott, Bang, Andrew, Berrang, Tanya, Clark, Haley, Hsu, Fred, Louie, Alexander V, Warner, Andrew, Palma, David A, Howell, Doris, Barry, Aisling, Dawson, Laura, Grendarova, Petra, Walker, Debra, Sinha, Rishi, Tsai, Jillian, Bahig, Houda, Thibault, Isabelle, Koul, Rashmi, Senthi, Sashendra, Phillips, Iain, Grose, Derek, Kelly, Paul, Armstrong, John, McDermott, Ronan, Johnstone, Candice, Vasan, Srini, Aherne, Noel, Harrow, Stephen, Liu, Mitchell

“…Radiotherapy delivery regimens can vary between a single fraction (SF) and multiple fractions (MF) given daily for up to several weeks depending on the…”
Get full text

A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer by Brade, Anthony, Jao, Kevin, Yu, Simon, Cheema, Parneet, Doucette, Sarah, Christofides, Anna, Schellenberg, Devin

“…Stage III non-small cell lung cancer (NSCLC) comprises a highly heterogenous group of patients with regards to patient fitness and tumour size and…”
Get full text

SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol by Olson, Robert, Schlijper, Roel, Chng, Nick, Matthews, Quinn, Arimare, Marco, Mathews, Lindsay, Hsu, Fred, Berrang, Tanya, Louie, Alexander, Mou, Benjamin, Valev, Boris, Laba, Joanna, Palma, David, Schellenberg, Devin, Lefresne, Shilo

“…Bone metastases in the lower spine and pelvis are effectively palliated with radiotherapy (RT), though this can come with side effects such as radiation…”
Get full text

EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy by Park, Walter G., MD, MSc, Yan, Brian M., MD, Schellenberg, Devin, MD, Kim, Jeff, MD, Chang, Daniel T., MD, Koong, Albert, MD, PhD, Patalano, Cheryl, RN, Van Dam, Jacques, MD, PhD

“…Background Image-guided radiation therapy (IGRT) accurately delivers a high dose of potentially tumoricidal radiation to its target while sparing adjacent…”
Get full text

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5 by Olson, Robert, Liu, Mitchell, Bergman, Alanah, Lam, Sonya, Hsu, Fred, Mou, Benjamin, Berrang, Tanya, Mestrovic, Ante, Chng, Nick, Hyde, Derek, Matthews, Quinn, Lund, Chad, Glick, Daniel, Pai, Howard, Basran, Parminder, Carolan, Hannah, Valev, Boris, Lefresene, Shilo, Tyldesley, Scott, Schellenberg, Devin

“…Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1-3 or 1-5…”
Get full text

Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial by Ko, Jenny J, Banerji, Shantanu, Blais, Normand, Brade, Anthony, Clelland, Cathy, Schellenberg, Devin, Snow, Stephanie, Wheatley-Price, Paul, Yuan, Ren, Melosky, Barbara

“…The PACIFIC trial showed a survival benefit with durvalumab through five years in stage III unresectable non-small cell lung cancer (NSCLC). However, optimal…”
Get full text

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer by Melosky, Barbara L, Leighl, Natasha B, Dawe, David, Blais, Normand, Wheatley-Price, Paul F, Chu, Quincy S-C, Juergens, Rosalyn A, Ellis, Peter M, Sun, Alexander, Schellenberg, Devin, Ionescu, Diana N, Cheema, Parneet K

“…Small-cell lung cancer (SCLC) is an aggressive, neuroendocrine tumour with high relapse rates, and significant morbidity and mortality. Apart from advances in…”
Get full text

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference by Mulder, Karen, Lim, Howard, Ravi, Deepti, Ahmed, Shahida, Brunet, Bryan, Davies, Janine, Doll, Corinne, Dueck, Dorie-Anna, Gordon, Vallerie, Hebbard, Pamela, Kim, Christina A, Le, Duc, Lee-Ying, Richard, McGhie, John Paul, Park, Jason, Renouf, Daniel J, Schellenberg, Devin, Wong, Ralph P W, Zaidi, Adnan, Ahmed, Shahid

“…Gastric, esophageal and gastro-esophageal junction cancers are associated with inferior outcomes. For early-stage disease, perioperative chemotherapy or…”
Get full text